From Polyphenols to Prodrugs: Bridging the Blood–Brain Barrier with Nanomedicine and Neurotherapeutics
Open accessThe DOI matches its Crossref record; 685 of the 685 references it cites were found in a registry or an index.
Abstract
Central nervous system disorders drive disability, yet many neuroactive candidates fail because the brain is a hard compartment to dose. Plant-derived molecules spanning polyphenols, alkaloids, terpenoids, and cannabinoids are attractive because their pleiotropic actions can engage oxidative stress, neuroinflammation, and circuit dysfunction. In practice, the blood–brain barrier (BBB) restricts most native phytochemicals through tight-junction selectivity, rapid metabolism, low solubility, and transporter-mediated efflux. Key gaps include poor standardization of exposure metrics, limited human-relevant BBB models, and few head-to-head studies that compare delivery platforms on the same payload and outcome. This review tackles the mismatch between mechanistic promise and reliable brain exposure that stalls translation. The objectives are to link phytochemical liabilities to enabling strategies in nanomedicine, alternative routes, and transporter-targeted prodrugs, and to propose decision-grade endpoints for translation. We synthesize evidence on BBB transport logic, nanocarrier families, targeting ligands, intranasal delivery, focused ultrasound-mediated opening, and prodrug approaches that hijack influx transporters, while foregrounding safety and chemistry, manufacturing, and controls (CMC) constraints. Here we highlight that effective neurotherapeutics emerge when chemistry, carrier, route, and measurement are co-designed rather than optimized in isolation. This framework can guide platform selection, de-risk first in-human studies, and sharpen trial endpoints. More broadly, it offers a transferable playbook for barrier-limited drug development across neurology, psychiatry, and oncology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Nevertheless, BBB constraints remain a central translational hurdle [126].”
From Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery (2026) · cites this paper as [126]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 401–600 of 685
Prodrug Approach as a Strategy to Enhance Drug Permeability
de Souza, M. M., Gini, A. L. R., Moura, J. A., Scarim, C. B., Chin, C. M., & dos Santos, J. L. (2025) · Pharmaceuticals · doi:10.3390/ph18030297 · Cited by 55
Barakji, J. A., Korang, S. K., Feinberg, J. B., Maagaard, M., Mathiesen, O., Gluud, C. N., & Jakobsen, J. C. (2023) · PLoS ONE · doi:10.1371/journal.pone.0267420 · Cited by 54
The mouse as a model for neuropsychiatric drug development
Howe, J. R., Bear, M. F., Golshani, P., Klann, E., Lipton, S. A., Mucke, L., Şahin, M., & Silva, A. J. (2018) · Current Biology · doi:10.1016/j.cub.2018.07.046 · Cited by 52
Asgharian, P., Quispe, C., Herrera‐Bravo, J., Sabernavaei, M., Hosseini, K., Forouhandeh, H., Ebrahimi, T., Sharafi-Badr, P., Tarhriz, V., Soofiyani, S. R., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.926607 · Cited by 52
de Lange, E. C. M., & Hammarlund‐Udenaes, M. (2022) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.2545 · Cited by 52
Nose‐to‐brain delivery of nanotherapeutics: Transport mechanisms and applications
Xu, K., Duan, S., Wang, W., Ouyang, Q., Qin, F., Guo, P., Hou, J., He, Z., Wei, W., & Qin, M. (2024) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1956 · Cited by 51
Disease-Induced Modulation of Drug Transporters at the Blood–Brain Barrier Level
Al Rihani, S. B., Darakjian, L. I., Deodhar, M., Dow, P., Turgeon, J., & Michaud, V. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073742 · Cited by 51
McDannold, N. J., Wen, P. Y., Reardon, D. A., Fletcher, S.-M. P., & Golby, A. J. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.06.036 · Cited by 51
Sebghatollahi, Z., Yogesh, R., Mahato, N., Kumar, V., Mohanta, Y. K., Baek, K.-H., & Mishra, A. K. (2025) · Antioxidants · doi:10.3390/antiox14040457 · Cited by 51
Chen, X., Xu, D. W., Yu, J., Song, X., Li, X., & Cui, Y. (2024) · Nutrients · doi:10.3390/nu16193380 · Cited by 50
Fan, S., Wang, W., Che, W., Xu, Y., Jin, C., Dong, L., & Xia, Q. (2025) · Metabolites · doi:10.3390/metabo15030201 · Cited by 50
A New Strategy for the Regulation of Neuroinflammation: Exosomes Derived from Mesenchymal Stem Cells
Ge, Y., Wu, J., Zhang, L., Huang, N., & Luo, Y. (2024) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-024-01460-x · Cited by 50
Design Considerations for Organ-Selective Nanoparticles
Baek, M., Hur, W., Kashiwagi, S., & Choi, H. S. (2025) · ACS Nano · doi:10.1021/acsnano.5c00484 · Cited by 50
Poles, M. Z., Nászai, A., Gulácsi, L., Czakó, B. L., Gál, K. G., Glenz, R. J., Dookhun, D., Rutai, A., Tallósy, S. P., Szabó, A., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.717157 · Cited by 49
de Koning, L. A., Vazquez-Matias, D. A., Beaino, W., Vugts, D. J., van Dongen, G. A. M. S., van der Flier, W. M., Ries, M. G., van Vuurden, D. G., Vijverberg, E. G. B., & van de Giessen, E. (2025) · The Journal of Prevention of Alzheimer s Disease · doi:10.1016/j.tjpad.2025.100204 · Cited by 49
Shen, X., Li, H., Zhang, B., Li, Y., & Zhu, Z. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26199793 · Cited by 48
Intestinal OCTN2- and MCT1-targeted drug delivery to improve oral bioavailability
Wang, G., Zhao, L., Jiang, Q., Sun, Y., Zhao, D., Sun, M., He, Z., sun, J., & Wang, Y. (2020) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2020.02.002 · Cited by 48
Targeting Brain Drug Delivery with Macromolecules Through Receptor-Mediated Transcytosis
Li, Y., Liu, R., & Zhao, Z. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17010109 · Cited by 48
Applications of cell penetrating peptide-based drug delivery system in immunotherapy
Du, J., Zhang, R., Jiang, S., Xiao, S., Liu, Y., Niu, Y., Zhao, W.-X., Wang, D., & Ma, X. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1540192 · Cited by 48
Li, J., Jiang, J., Wu, J., Bao, X., & Sanai, N. (2020) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.2021 · Cited by 48
Revealing Angiopep-2/LRP1 Molecular Interaction for Optimal Delivery to Glioblastoma (GBM)
di Polidoro, A. C., Cafarchio, A., Vecchione, D., Donato, P., de Nola, F., & Torino, E. (2022) · Molecules · doi:10.3390/molecules27196696 · Cited by 48
Gupta, M., Feng, J., & Bhisetti, G. (2024) · Molecules · doi:10.3390/molecules29061264 · Cited by 48
Plant-Derived Extracellular Vesicles: Natural Nanocarriers for Biotechnological Drugs
Calzoni, E., Bertoldi, A., Cusumano, G., Buratta, S., Urbanelli, L., & Emiliani, C. (2024) · Processes · doi:10.3390/pr12122938 · Cited by 47
A systematic review of the antidepressant effects of curcumin: Beyond monoamines theory
Matias, J. N., de Souza, G. A., Campanari, G. S. D. S., Guiguer, É. L., Araújo, A. C., Buglio, D. S., & Barbalho, S. M. (2021) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867421998795 · Cited by 47
Self-citationSaleh, S. R., Abd-Elmegied, A., Madhy, S. A., Khattab, S. N., Sheta, E., Elnozahy, F. Y., Mehanna, R. A., Ghareeb, D. A., & Abdel-Monem, N. M. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.124218 · Cited by 47
Chen, L., Guan, Y., Wang, S., Han, X., Guo, F., & Wang, Y. (2025) · Neurotherapeutics · doi:10.1016/j.neurot.2025.e00722 · Cited by 47
Ureña-Vacas, I., Belén, A. D. L. R. M., Serrano, D. R., & González‐Burgos, E. (2024) · Current Research in Biotechnology · doi:10.1016/j.crbiot.2024.100235 · Cited by 46
Metal nanoparticles in neuroinflammation: impact on microglial dynamics and CNS function
Alaei, M., Koushki, K., Taebi, K., Taba, M. Y., Hedayati, S. K., & Shahbaz, S. K. (2025) · RSC Advances · doi:10.1039/d4ra07798a · Cited by 46
Shamul, J. G., Wang, Z., Gong, H., Ou, W., White, A. M., Garcia, D. P. M., Gu, S., Clyne, A. M., Quiñones‐Hinojosa, A., & He, X. (2024) · Nature Biomedical Engineering · doi:10.1038/s41551-024-01250-2 · Cited by 45
Mehrdadi, S. (2022) · Advanced Pharmaceutical Bulletin · doi:10.34172/apb.2023.062 · Cited by 45
Wei, H.-X., Liu, M.-H., Wang, T.-Y., Shih, M., Yu, J., & Yeh, Y. (2025) · Biomacromolecules · doi:10.1021/acs.biomac.4c01202 · Cited by 45
Zubair, M., Abouelnazar, F. A., Iqbal, M. A., Pan, J., Zheng, X., Chen, T., Shen, W., Yin, J., Yan, Y., Liu, P., et al. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1563427 · Cited by 45
The role of Complement in Post-Transfusion Hemolysis and Hyperhemolysis Reaction
Roumenina, L. T., Bartolucci, P., & Pirenne, F. (2019) · Transfusion Medicine Reviews · doi:10.1016/j.tmrv.2019.09.007 · Cited by 44
In vitro models of the blood-brain barrier: building in physiological complexity
Katt, M. E., & Shusta, E. V. (2020) · Current Opinion in Chemical Engineering · doi:10.1016/j.coche.2020.07.002 · Cited by 44
Wu, K., Li, X., Zhou, Z., Zhao, Y., Su, M., Cheng, Z., Wu, X., Huang, Z., Jin, X., Li, J., et al. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1330855 · Cited by 44
Uptake Transporters at the Blood–Brain Barrier and Their Role in Brain Drug Disposition
Parvez, M. M., Sadighi, A., Ahn, Y., Keller, S. F., & Enoru, J. O. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15102473 · Cited by 43
Kumar, V., Banerjee, A., & Roy, K. (2024) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.4c00433 · Cited by 43
Elbaz, M., Ad-El, N., Chulanova, Y., Brier, D., Goldsmith, M., Bismuth, M., Brosque, A., Sher, D., Gutkin, A., Bar-On, D., et al. (2025) · doi:10.1101/2025.01.23.634427 · Cited by 43
Porro, G., Basile, M., Xie, Z., Tuveri, G. M., Battaglia, G., & Lopes, C. D. F. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115637 · Cited by 42
Tanaka, M. (2025) · Biomedicines · doi:10.3390/biomedicines13010167 · Cited by 42
Self-citationYoussef, E. M., Weddle, K., Zimmerman, L., & Palmer, D. (2025) · Drug Safety · doi:10.1007/s40264-025-01596-9 · Cited by 42
Ha, I. H., Lim, C., Kim, Y., Moon, Y., Han, S., & Moon, W. (2021) · Korean Journal of Radiology · doi:10.3348/kjr.2020.0816 · Cited by 42
Pielenhofer, J., Meiser, S. L., Gogoll, K., Ciciliani, A.-M., Denny, M., Klak, M., Lang, B. M., Staubach, P., Grabbe, S., Schild, H., et al. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15020514 · Cited by 42
Pinkiewicz, M., Pinkiewicz, M., Walecki, J. M., Zaczyński, A., & Zawadzki, M. (2024) · Cancers · doi:10.3390/cancers16010236 · Cited by 42
Rassu, G., Sorrenti, M., Catenacci, L., Pavan, B., Ferraro, L., Gavini, E., Bonferoni, M. C., Giunchedi, P., & Dalpiaz, A. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15061578 · Cited by 42
Oosthoek, M., Vermunt, L., de Wilde, A., Bongers, B., Antwi‐Berko, D., Scheltens, P., van Bokhoven, P., Vijverberg, E. G. B., & Teunissen, C. E. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01456-1 · Cited by 42
Tanaka, M. (2025) · doi:10.20944/preprints202412.0679.v2 · Cited by 42
Self-citationMurakami, T., Bodor, E., & Bodor, N. (2023) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2023.2203857 · Cited by 41
Israel, L. L., Galstyan, A., Cox, A., Shatalova, E. S., Sun, T., Rashid, M.-H., Grodzinski, Z., Chiechi, A., Fuchs, D.-T., Patil, R., et al. (2022) · ACS Nano · doi:10.1021/acsnano.1c10034 · Cited by 41
Milić, J., Đoković, J. B., Nikolić, I., Mitrović, J. R., Pantelić, I., Savic, S. D., & Savić, M. M. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15020443 · Cited by 41
Wu, X., Shu, Y., Zheng, Y., Zhang, P., Cong, H., Zou, Y., Cai, H., & Zha, Z. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17081037 · Cited by 41
Nájera-Maldonado, L., Parra-González, M., Peralta-Cuevas, E., Gutierrez-Onofre, A. J., Garcia-Atutxa, I., & Villanueva-Flores, F. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17091169 · Cited by 40
A Promising Approach: Magnetic Nanosystems for Alzheimer’s Disease Theranostics
Chaparro, C. I. P., Simões, B. T., Borges, J. P., Castanho, M. A. R. B., Soares, P. I. P., & Neves, V. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15092316 · Cited by 40
Receptor–mediated transcytosis of macromolecules across the blood–brain barrier
Baghirov, H. (2023) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2023.2255138 · Cited by 40
Omar, S. H., Osman, R., Mamdouh, W., Abdel‐Bar, H. M., & Awad, G. A. S. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.09.170 · Cited by 40
Engineered and Mimicked Extracellular Nanovesicles for Therapeutic Delivery
Poinsot, V., Pizzinat, N., & Ong‐Meang, V. (2024) · Nanomaterials · doi:10.3390/nano14070639 · Cited by 40
Wang, G., Zhou, X., Pang, X., Ma, K., Li, L., Song, Y., Hou, D., & Wang, X. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1625821 · Cited by 40
Wu, C., Szalontay, L., Pouliopoulos, A. N., Bae, S., Berg, X., Wei, H.-J., Carrion, A. W., Kokossis, D., Sethi, C., Fino, J., et al. (2025) · Science Translational Medicine · doi:10.1126/scitranslmed.adq6645 · Cited by 40
Schreiner, T. G., Menéndez‐González, M., Schreiner, O. D., & Ciobanu, R. C. (2025) · Biomedicines · doi:10.3390/biomedicines13092167 · Cited by 39
Progress in the development of kynurenine and quinoline-3-carboxamide-derived drugs
Boros, F. A., & Vécsei, L. (2020) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2020.1813716 · Cited by 39
Janicka, M., Sztanke, M., & Sztanke, K. (2024) · Molecules · doi:10.3390/molecules29020287 · Cited by 39
Bharadwaj, P., Roullin, G., & Chain, J. L. (2025) · Nanoscale · doi:10.1039/d5nr02548f · Cited by 39
Vuillemenot, B. R., Korte, S., Wright, T. L., Adams, E. L., Boyd, R. B., & Butt, M. T. (2016) · Toxicological Sciences · doi:10.1093/toxsci/kfw072 · Cited by 38
Barbalho, S. M., Leme Boaro, B., da Silva Camarinha Oliveira, J., Patočka, J., Barbalho Lamas, C., Tanaka, M., & Laurindo, L. F. (2025) · Pharmaceuticals · doi:10.3390/ph18010133 · Cited by 38
Self-citationPinkiewicz, M., Zaczyński, A., Walecki, J. M., & Zawadzki, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26157050 · Cited by 38
He, C., Wu, Z., Zhuang, M., Li, X., Xue, S., Xu, S., Xu, J., Wu, Z., & Lu, M. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-02074-z · Cited by 38
Hazrati, E., Eftekhar, S. P., Mosaed, R., Dini, S. S., & Namazi, M. (2024) · Molecular Pain · doi:10.1177/17448069241275097 · Cited by 38
Guo, H., & Mi, P. (2024) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1988 · Cited by 37
Kamath, A. P., Nayak, P. G., John, J., Mutalik, S., Balaraman, A. K., & Nandakumar, K. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.110096 · Cited by 37
McIntyre, R. S., Kwan, A. T. H., Mansur, R. B., Oliveira-Maia, A. J., Teopiz, K. M., Maletic, V., Suppes, T. M., Stahl, S. M., & Rosenblat, J. D. (2025) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20230902 · Cited by 37
Duan, C., Liu, W., Tao, P., Liang, F., Chen, Y., Xiao, X., Zhang, G., Chen, Y., & Hao, C. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics14010023 · Cited by 37
A New Perspective on Regenerative Medicine: Plant-Derived Extracellular Vesicles
Zuo, Y., Zhang, J., Sun, B., Wang, X., Wang, R., Tian, S., & Miao, M. (2025) · Biomolecules · doi:10.3390/biom15081095 · Cited by 37
Hemopexin as an Inhibitor of Hemolysis-Induced Complement Activation
Poillerat, V., Gentinetta, T., Léon, J., Wassmer, A., Edler, M., Torset, C., Luo, D., Tuffin, G., & Roumenina, L. T. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01684 · Cited by 36
Hugon, G., Goutal, S., Dauba, A., Breuil, L., Larrat, B., Winkeler, A., Novell, A., & Tournier, N. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13111752 · Cited by 36
Network models to enhance the translational impact of cross-species studies
Brynildsen, J. K., Rajan, K., Henderson, M. X., & Bassett, D. S. (2023) · Nature reviews. Neuroscience · doi:10.1038/s41583-023-00720-x · Cited by 36
Neaz, S., Alam, M. M., & Imran, A. B. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e39917 · Cited by 36
Pardridge, W. M., & Chou, T. (2021) · Pharmaceuticals · doi:10.3390/ph14060535 · Cited by 35
Zhang, W., Liu, Q. Y., Haqqani, A. S., Liu, Z., Sodja, C., Leclerc, S., Baumann, E., Delaney, C. E., Brunette, E., & Stanimirovic, D. B. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15051563 · Cited by 35
NEO100 enables brain delivery of blood‒brain barrier impermeable therapeutics
Wang, W., Marín‐Ramos, N. I., He, H., Zeng, S., Cho, H., Swenson, S. D., Zheng, L., Epstein, A. L., Schönthal, A. H., Hofman, F. M., et al. (2020) · Neuro-Oncology · doi:10.1093/neuonc/noaa206 · Cited by 35
Ghaemi, B., Tanwar, S., Singh, A., Arifin, D. R., McMahon, M. T., Barman, I., & Bulte, J. W. M. (2024) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.3c14908 · Cited by 35
The nasal route for nose-to-brain drug delivery: advanced nasal formulations for CNS disorders
Papakyriakopoulou, P., & Valsami, G. N. (2025) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2025.2489553 · Cited by 35
Godos, J., Carota, G., Caruso, G., Micek, A., Frías-Toral, E., Giampieri, F., Ballester, J. B., Rodríguez, C. L., Quiles, J. L., Battino, M., et al. (2025) · EXCLI journal · doi:10.17179/excli2025-8779 · Cited by 35
Dubczak, J., Reid, N., & Tsuchiya, M. (2021) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2021.105716 · Cited by 34
Prediction of vascular injury by cavitation microbubbles in a focused ultrasound field
Xie, Y., Hu, J., Lei, W., & Qian, S. (2022) · Ultrasonics Sonochemistry · doi:10.1016/j.ultsonch.2022.106103 · Cited by 34
Piantino, M., Louis, F., Shigemoto‐Mogami, Y., Nakayama-Kitamura, K., Sato, K., Yamaguchi, T., Kawabata, K., Yamamoto, S., Iwasaki, S., Hirabayashi, H., et al. (2022) · Materials Today Bio · doi:10.1016/j.mtbio.2022.100232 · Cited by 34
Kato, N., Yamada, S., Suzuki, R., Iida, Y., Matsumoto, M., Fumoto, S., Arima, H., Mukai, H., & Kawakami, S. (2023) · Drug Delivery · doi:10.1080/10717544.2023.2173333 · Cited by 34
Advances in multimodal imaging techniques in nanomedicine: enhancing drug delivery precision
Mishra, V. K., Kumari, N., Vyas, M., Aljabali, A. A. A., Chattaraj, A., & Mishra, Y. (2025) · RSC Advances · doi:10.1039/d5ra03255e · Cited by 34
Multiscale Profiling of Nanoscale Metal‐Organic Framework Biocompatibility and Immune Interactions
Zhuang, Y., Mendes, B. B., Menon, D., Oliveira, J., Chen, X., Duman, F. D., Conniot, J., Argandona, S. M., Liu, X., Zhang, S., et al. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202501809 · Cited by 34
Revamping Parkinson’s disease therapy using PLGA-based drug delivery systems
Lababidi, J. M., & Azzazy, H. M. E.-S. (2025) · npj Parkinson s Disease · doi:10.1038/s41531-025-01081-1 · Cited by 34
Bresinskya, M., & Göpferich, A. M. (2025) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2025.114634 · Cited by 33
Improving the Dissolution Rate and Bioavailability of Curcumin via Co-Crystallization
Wang, H., Zheng, C., Tian, F., Xiao, Z., Sun, Z., Lu, L., Dai, W., Zhang, Q., & Mei, X. (2024) · Pharmaceuticals · doi:10.3390/ph17040489 · Cited by 33
Neuroinflammation and Natural Antidepressants: Balancing Fire with Flora
Figueiredo Godoy, A. C., Frota, F. F., Araújo, L. P., Valenti, V. E., Pereira, E. D. S. B. M., Detregiachi, C. R. P., Galhardo, C. M., Caracio, F. C., Haber, R. S. A., Fornari Laurindo, L., et al. (2025) · doi:10.20944/preprints202504.0573.v2 · Cited by 33
Self-citationThe Indissociable Triad: Vascular Impairment, Muscle Atrophy, and Cognitive DeclinePreprint
de Lima, E. P., Tanaka, M., Lamas, C. B., et al. (2024) · Preprints.org · doi:10.20944/preprints202408.0728.v1 · Cited by 33
Self-citationUpadhyay, R. K., Ghosh, P., & Desavathu, M. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.124866 · Cited by 32
Neuroinflammation and Natural Antidepressants: Balancing Fire with Flora
Figueiredo Godoy, A. C., Frota, F. F., Araújo, L. P., Valenti, V. E., Pereira, E. D. S. B. M., Detregiachi, C. R. P., Galhardi, C. M., Caracio, F. C., Haber, R. S. A., Fornari Laurindo, L., et al. (2025) · Biomedicines · doi:10.3390/biomedicines13051129 · Cited by 32
Self-citationSoncin, S., Cicero, V. L., Astori, G., Soldati, G., Gola, M., Sürder, D., & Moccetti, T. (2009) · Journal of Translational Medicine · doi:10.1186/1479-5876-7-78 · Cited by 32
El-Nahas, A. E., Elbedaiwy, H. M., Masoud, I. M., Aly, R. G. M., Helmy, M. W., & El-Kamel, A. H. (2023) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2023.04.008 · Cited by 32
Spielvogel, C. P., Schindler, N., Schröder, C., Stellnberger, S. L., Wadsak, W., Mitterhauser, M., Papp, L., Hacker, M., Pichler, V., & Vraka, C. (2025) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.4c02212 · Cited by 32
Giannakou, C., Park, M. V. D. Z., Bosselaers, I. E. M., de Jong, W. H., van der Laan, J. W., Loveren, H. V., Vandebriel, R. J., & Geertsma, R. E. (2020) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1633 · Cited by 31
Pharmacokinetics, biodistribution and toxicology of novel cell-penetrating peptides
Réveret, L., Leclerc, M., Morin, F., Émond, V., & Calon, F. (2023) · Scientific Reports · doi:10.1038/s41598-023-37280-0 · Cited by 31
O'Donnell, A., Moollan, A., Baneham, S., Önal, M. Ö., Pabari, R. M., Cox, D. M., Kirby, B. P., & Ramtoola, Z. (2014) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12347 · Cited by 30
PepH3-modified nanocarriers for delivery of therapeutics across the blood-brain barrier
Szecskó, A., Mészáros, M., Simões, B. T., Cavaco, M. C., Chaparro, C. I. P., Porkoláb, G., Castanho, M. A. R. B., Deli, M. A., Neves, V., & Veszelka, S. (2025) · Fluids and Barriers of the CNS · doi:10.1186/s12987-025-00641-0 · Cited by 30
Zhang, W., Refaat, A., Li, H., Zhu, D., Tong, Z., Nicolazzo, J. A., Peng, B., Bai, H., Esser, L., & Voelcker, N. H. (2025) · Advanced Functional Materials · doi:10.1002/adfm.202425165 · Cited by 30
Meng, Y., Kalia, L. V., Kalia, S. K., Hamani, C., Huang, Y., Hynynen, K., Lipsman, N., & Davidson, B. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16060719 · Cited by 30
Huttunen, J., Gynther, M., Vellonen, K., & Huttunen, K. M. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.118714 · Cited by 30
Polyphenols in the Central Nervous System: Cellular Effects and Liposomal Delivery Approaches
Kaluza, M., Ksiazek-Winiarek, D. J., Szpakowski, P., Czpakowska, J., Fijalkowska, J., & Glabinski, A. R. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26136477 · Cited by 30
Quinoline Quest: Kynurenic Acid Strategies for Next-Generation Therapeutics via Rational Drug Design
Tanaka, M., Szatmári, I., & Vécsei, L. (2025) · doi:10.20944/preprints202503.2399.v1 · Cited by 30
Self-citationQuinoline Quest: Kynurenic Acid Strategies for Next-Generation Therapeutics via Rational Drug Design
Tanaka, M., Szatmári, I., & Vécsei, L. (2025) · Pharmaceuticals · doi:10.3390/ph18050607 · Cited by 29
Self-citationKato, R., Zhang, L., Kinatukara, N., Huang, R., Asthana, A., Weber, C., Xia, M., Xu, X., & Shah, P. (2025) · Scientific Reports · doi:10.1038/s41598-025-90888-2 · Cited by 29
Watanabe, D., Nakagawa, S., Morofuji, Y., Tóth, A. E., Vastag, M., Aruga, J., Niwa, M., & Deli, M. A. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13091484 · Cited by 29
Adjuvant convection-enhanced delivery for the treatment of brain tumors
Kreatsoulas, D. C., Damante, M. A., Cua, S., & Lonser, R. R. (2024) · Journal of Neuro-Oncology · doi:10.1007/s11060-023-04552-8 · Cited by 29
Polyamidoamine Dendrimers: Brain-Targeted Drug Delivery Systems in Glioma Therapy
Yan, X., & Chen, Q. (2024) · Polymers · doi:10.3390/polym16142022 · Cited by 28
Burgio, F., Gaiser, C., Brady, K., Gatta, V., Class, R., Schrage, R., & Suter‐Dick, L. (2023) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-023-01404-x · Cited by 28
Increased/Targeted Brain (Pro)Drug Delivery via Utilization of Solute Carriers (SLCs)
Huttunen, J., Adla, S. K., Markowicz-Piasecka, M., & Huttunen, K. M. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14061234 · Cited by 28
Seyyedi-Mansour, S., Carpena, M., Barciela, P., Perez-Vazquez, A., Assadpour, E., Prieto, M. A., & Jafari, S. M. (2025) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2025.103457 · Cited by 28
The effects of dose, valency, and affinity on TfR-mediated brain delivery in vivo
Bonvicini, G., Singh, S. G., Sandersjöö, L., Sehlin, D., Syvänen, S., & Andersson, K. G. (2025) · Fluids and Barriers of the CNS · doi:10.1186/s12987-025-00643-y · Cited by 28
Kumar, D. M., & Talwar, P. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1616144 · Cited by 28
Wang, K., Yang, R., Li, J., Wang, H., Wan, L., & He, J. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1591438 · Cited by 27
Tanaka, M. (2024) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/197425 · Cited by 27
Self-citationSZR-104, a Novel Kynurenic Acid Analogue with High Permeability through the Blood–Brain Barrier
Molnár, K., Lőrinczi, B., Fazakas, C., Szatmári, I., Fülöp, F., Kmetykó, N., Berkecz, R., Ilisz, I., Krizbai, I. A., Wilhelm, I., et al. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13010061 · Cited by 27
Characterization of the blood–brain barrier in genetically diverse laboratory mouse strains
Schaffenrath, J., Huang, S.-F., Wyss, T., Delorenzi, M., & Keller, A. (2021) · Fluids and Barriers of the CNS · doi:10.1186/s12987-021-00269-w · Cited by 27
Morrison, J. I., Petrovic, A., Metzendorf, N. G., Rofo, F., Yılmaz, C. U., Stenler, S., Laudon, H., & Hultqvist, G. (2023) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.2c00768 · Cited by 27
A claudin5-binding peptide enhances the permeability of the blood-brain barrier in vitro
Trevisani, M., Berselli, A., Alberini, G., Centonze, E., Vercellino, S., Cartocci, V., Millo, E., Ciobanu, D. Z., Braccia, C., Armirotti, A., et al. (2025) · Science Advances · doi:10.1126/sciadv.adq2616 · Cited by 27
Advancing through the blood-brain barrier: mechanisms, challenges and drug delivery strategies
Vargas, R., Martínez-Martínez, N., Lizano-Barrantes, C., Molina, J. A. P., García‐Montoya, E., Pérez‐Lozano, P., Suñé-Negre, J. M., Suñé, C., & Suñé-Pou, M. (2025) · ADMET & DMPK · doi:10.5599/admet.2988 · Cited by 27
Chauhan, M., Basu, S. M., Qasim, M., & Giri, J. (2023) · Nanoscale · doi:10.1039/d2nr05218k · Cited by 26
Liang, K., Li, Y., Kang, J., Liu, B., Zhang, D., Wang, L., Wang, W. J., & Wang, Q. (2024) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2024.100963 · Cited by 26
A hydrogel model of the human blood-brain barrier using differentiated stem cells
Singh, N. R., Gromnicova, R., Brachner, A., Kraev, I., Romero, I. A., Neuhaus, W., & Male, D. K. (2023) · PLoS ONE · doi:10.1371/journal.pone.0283954 · Cited by 26
Murphy, N., Ramakrishnan, N., Vo-Le, B., Vo‐Le, B., Smith, M. A., Iqbal, T., Swann, A. C., Mathew, S. J., & Lijffijt, M. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-020-00917-z · Cited by 26
Tampio, J., Huttunen, J., Montaser, A. B., & Huttunen, K. M. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02045-7 · Cited by 26
Goldeman, C., Andersen, M. V., Al-Robai, A., Buchholtz, T., Svane, N., Ozgür, B., Holst, B., Shusta, E. V., Hall, V. J., Saaby, L., et al. (2020) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2020.105577 · Cited by 26
Apolipoprotein and LRP1-Based Peptides as New Therapeutic Tools in Atherosclerosis
Amaro, A. B., Curco, A. S., García, E., Julve, J., Rives, J., Benítez, S., & Llorente‐Cortés, V. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10163571 · Cited by 26
Javed, M. N., Aslam, M., Deeb, H., Nicola, M. K., Mirza, M. A., Alam, M. S., Akhtar, M. H., & Waziri, A. (2021) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527320666210706104240 · Cited by 26
A critical analysis of neuro-oncology clinical trials
Kim, Y., Armstrong, T. S., Gilbert, M. R., & Celiku, O. (2023) · Neuro-Oncology · doi:10.1093/neuonc/noad036 · Cited by 26
Synthesis and biophysical evaluation of carbosilane dendrimers as therapeutic siRNA carriers
Zawadzki, S., Ortiz, Á. M., Okła, E., Kędzierska, M., García‐Gallego, S., Ortega, P., de la Mata, F. J., Michlewska, S., Makowski, T., Йонов, М., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-51238-w · Cited by 26
Colclough, N., Alluri, R. V., Tucker, J. W., Gozalpour, E., Li, D., Du, H., Li, W., Harlfinger, S., O’Neill, D. J., Sproat, G., et al. (2023) · Drug Metabolism and Disposition · doi:10.1124/dmd.123.001476 · Cited by 26
Martos, D., Lőrinczi, B., Szatmári, I., Vécsei, L., & Tanaka, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063394 · Cited by 25
Self-citationKocsis, A. E., Kucsápszky, N., Santa-Maria, A. R., Hunyadi, A., Deli, M. A., & Walter, F. R. (2025) · Nutrients · doi:10.3390/nu17050766 · Cited by 25
Kleindienst, A., Dunbar, J. G., Glisson, R., Okuno, K., & Marmarou, A. (2006) · Springer eBooks · doi:10.1007/3-211-30714-1_55 · Cited by 25
Non-animal models for blood–brain barrier permeability evaluation of drug-like compounds
Dehnbostel, F. O., Dixit, V. A., Preißner, R., & Banerjee, P. (2024) · Scientific Reports · doi:10.1038/s41598-024-59734-9 · Cited by 25
Yu, T., Wei, Z., Wang, J., Song, C., Huang, W., Zhang, P., Shi, J., Zhang, Y., Jiang, M., Wang, D., et al. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.156646 · Cited by 25
Gowrikumar, S., Tarudji, A. W., McDonald, B. Z., Balusa, S. S., Kievit, F. M., & Dhawan, P. (2025) · Tissue Barriers · doi:10.1080/21688370.2025.2470482 · Cited by 25
Parvar, S. J., Wong, C. I., Lewis, A., Szychot, E., Morris, C. J., Shorthouse, D., & Dziemidowicz, K. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115657 · Cited by 25
Maiuolo, J., Gliozzi, M., Musolino, V., Scicchitano, M., Carresi, C., Scarano, F., Bosco, F., Nucera, S., Ruga, S., Zito, M. C., et al. (2018) · doi:10.20944/preprints201808.0223.v1 · Cited by 25
Tanaka, M., Battaglia, S., & Liloia, D. (2025) · Biomedicines · doi:10.3390/biomedicines13051045 · Cited by 24
Self-citationRecent advances in biomimetic nanodelivery systems for the treatment of depression
Jiang, P., & Li, J. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.101781 · Cited by 24
Liu, Y., Wang, Q., Feng, Z., Qin, M., Zhang, Z., Jiang, J., Ren, T., Liu, X., Brinker, C. J., Zhao, Y., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-61434-5 · Cited by 24
Charge-switchable cell-penetrating peptides for rerouting nanoparticles to glioblastoma treatment
Mendes, M., Nunes, S. C. C., Cova, T. F. G. G., Branco, F., Dyrks, M., Koksch, B., Vale, N., Sousa, J., Pais, A. A. C. C., & Vitorino, C. (2024) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2024.113983 · Cited by 24
From Microbial Switches to Metabolic Sensors: Rewiring the Gut–Brain Kynurenine Circuit
Tanaka, M., & Vécsei, L. (2025) · doi:10.20944/preprints202506.0880.v1 · Cited by 24
Self-citationKarad, V., & Gupta, G. L. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04298-2 · Cited by 23
Haro-Martínez, E., Muscolino, E., Moral, N., Durán, J., & Fornaguera, C. (2025) · Drug Delivery and Translational Research · doi:10.1007/s13346-025-01887-9 · Cited by 23
From Microbial Switches to Metabolic Sensors: Rewiring the Gut–Brain Kynurenine Circuit
Tanaka, M., & Vécsei, L. (2025) · Biomedicines · doi:10.3390/biomedicines13082020 · Cited by 23
Self-citationBahrami, K., Järvinen, J., Laitinen, T., Reinisalo, M., Honkakoski, P., Poso, A., Huttunen, K. M., & Rautio, J. (2022) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.2c00594 · Cited by 23
Ozgür, B., Puris, E., Brachner, A., Appelt‐Menzel, A., Oerter, S., Balzer, V., Holst, M. R., Christiansen, R. F., Hyldig, K., Buckley, S. T., et al. (2023) · Fluids and Barriers of the CNS · doi:10.1186/s12987-023-00501-9 · Cited by 23
Chatterjee, S., Deshpande, A. A., & Shen, H. (2023) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.2345 · Cited by 22
Cation-free siRNA-cored nanocapsules for tumor-targeted RNAi therapy
Huang, X., Li, J., Li, J., Li, G., Liang, Z., Chen, H., Xu, C., Zhou, J., Huang, J., & Deng, S. (2023) · Acta Biomaterialia · doi:10.1016/j.actbio.2023.03.001 · Cited by 22
Lei, K., Zhou, L., Dan, M., Yang, F., Jian, T., Xin, J., Yu, Z., & Wang, Y. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17030280 · Cited by 22
Tujula, I., Hyvärinen, T., Lotila, J., Rogal, J., Voulgaris, D., Sukki, L., Tornberg, K., Korpela, K., Jäntti, H., Malm, T., et al. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02304-x · Cited by 22
Szabó, Á., Galla, Z., Spekker, E., Szűcs, M., Martos, D., Takeda, K., Ozaki, K., Inoue, H., Yamamoto, S., Toldi, J., et al. (2025) · Frontiers in Bioscience-Landmark · doi:10.31083/fbl25706 · Cited by 21
Self-citationMishra, K., Rana, R., Tripathi, S., Siddiqui, S., Yadav, P. K., Yadav, P. N., & Chourasia, M. K. (2023) · Neurochemical Research · doi:10.1007/s11064-023-03955-3 · Cited by 21
Blood–Brain Barrier Solute Carrier Transporters and Motor Neuron Disease
Latif, S., & Kang, Y. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14102167 · Cited by 21
-, S. S. S., -, K. P. S., & -, S. H. (2025) · International Journal on Science and Technology · doi:10.71097/ijsat.v16.i2.6473 · Cited by 21
From Monoamines to Systems Psychiatry: Rewiring Depression Science and Care (1960s–2025)
Tanaka, M. (2025) · Biomedicines · doi:10.3390/biomedicines14010035 · Cited by 20
Self-citationA novel oral prodrug-targeting transporter MCT 1: 5-fluorouracil-dicarboxylate monoester conjugates
Sun, Y., Zhao, D., Wang, G., et al. (2019) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2019.04.001 · Cited by 20
Zhu, M., Liu, Q., Chen, Z., Liu, J., Zhang, Z., Tian, J., Wang, X., Xiong, Y., Chen, Q., Huang, X., et al. (2025) · ACS Nano · doi:10.1021/acsnano.4c12808 · Cited by 20
Post-Stroke Recovery: A Review of Hydrogel-Based Phytochemical Delivery Systems
Musa, I., Rotaru-Zăvăleanu, A. D., Sfredel, V., Aldea, M., Greșiță, A., & Glăvan, D. (2025) · Gels · doi:10.3390/gels11040260 · Cited by 20
Harnessing Preclinical Data as a Predictive Tool for Human Brain Tissue Targeting
Patel, N. C., Feng, B., Hou, X., West, M. A., Trapa, P. E., Sciabola, S., Verhoest, P. R., Liras, J. L., Maurer, T. S., & Wager, T. T. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00807 · Cited by 19
Multimodal platform for assessing drug distribution and response in clinical trials
Lopez, B. G. C., Kohale, I. N., Du, Z., Korsunsky, I., Abdelmoula, W. M., Dai, Y., Stopka, S. A., Gaglia, G., Randall, E. C., Regan, M. S., et al. (2021) · Neuro-Oncology · doi:10.1093/neuonc/noab197 · Cited by 19
Mehta, P., Soliman, A., Rodríguez‐Vera, L., Schmidt, S., Muniz, P., Rodríguez, M., Forcadell, M., Gonzalez-Perez, E., & Vozmediano, V. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16020226 · Cited by 19
Virtanen, P. S., Ortiz, K. J., Patel, A., Blocher, W. A., & Richardson, A. M. (2024) · Current Oncology Reports · doi:10.1007/s11912-024-01497-7 · Cited by 19
Cyclodextrin-Containing Drug Delivery Systems and Their Applications in Neurodegenerative Disorders
Xing, Y., Meng, B., & Chen, Q. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251910834 · Cited by 19
Bayesian Optimization for Efficient Multiobjective Formulation Development of Biologics
Waibel, I., Schneider, T. N., Fischer, F. J., Dumnoenchanvanit, P., Kulakova, A., Nguyen, T. D., Egebjerg, T., Bertelsen, S., Lorenzen, N., & Arosio, P. (2025) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5c00591 · Cited by 19
Barbalho, S. M., Boaro, B. L., Oliveira, J. D. S. C., et al. (2025) · Preprints.org · doi:10.20944/preprints202412.1696.v2 · Cited by 19
Self-citationAdipoRon’s Impact on Alzheimer’s Disease—A Systematic Review and Meta-Analysis
Barbalho, S. M., Laurindo, L. F., de Oliveira Zanuso, B., da Silva, R. M. S., Gallerani Caglioni, L., Nunes Junqueira de Moraes, V. B. F., Fornari Laurindo, L., Dogani Rodrigues, V., da Silva Camarinha Oliveira, J., Beluce, M. E., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26020484 · Cited by 18
Self-citationPatel, W., Rimmer, L. J., Smith, M., Moss, L., Smith, M. A., Snodgrass, H. R., Pirmohamed, M., Alfirevic, A., & Dickens, D. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.0c00727 · Cited by 18
Chaves, C., Do, T.-M., Cegarra, C., Roudières, V., Tolou, S., Thill, G., Rocher, C., Didier, M., & Lesuisse, D. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12100967 · Cited by 18
Dual-Ligand Synergistic Targeting Anti-Tumor Nanoplatforms with Cascade-Responsive Drug Release
Luo, F., Zhong, T., Chen, Y., Guo, Q., Tao, L., Shen, X., Fan, Y., & Wu, X. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15072014 · Cited by 18
Natural drug delivery systems for the treatment of neurodegenerative diseases
Kaspute, G., Ramanavičius, A., & Prentice, U. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-10286-9 · Cited by 18
Prediction Models for Brain Distribution of Drugs Based on Biomimetic Chromatographic Data
Vallianatou, T., Tsopelas, F. N., & Tsantili‐Kakoulidou, A. (2022) · Molecules · doi:10.3390/molecules27123668 · Cited by 17
Mollnes, T. E., Storm, B., Brekke, O., Nilsson, P. H., & Lambris, J. D. (2022) · Seminars in Immunology · doi:10.1016/j.smim.2022.101604 · Cited by 17
Evaluation of Tight Junction Integrity in Brain Endothelial Cells Using Confocal Microscopy
Alluri, H., Peddaboina, C. S., & Tharakan, B. (2023) · Methods in molecular biology · doi:10.1007/978-1-0716-3429-5_21 · Cited by 17
Gonen, O. M., Porter, T., Wang, B., Xue, F., Ma, Y., Song, L., Sun, P., Fan, W., & Shen, Y. (2025) · Clinical and Translational Science · doi:10.1111/cts.70151 · Cited by 17
Lee, D., Kim, J., Cong, R., Park, J., Nguyen, C. H. B., Park, K., Kang, K., & Shim, S. (2025) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.14339 · Cited by 17
Yuan, N. Y., Richards, W. D., Parham, K. T., Clark, S. G., Greuel, K., Polzin, B. J., Smith, S. W., & Lebakken, C. S. (2025) · Current Research in Toxicology · doi:10.1016/j.crtox.2025.100252 · Cited by 17
Kirit, E., Gokce, C., Altun, B., & Yılmazer, A. (2025) · ACS Omega · doi:10.1021/acsomega.5c02206 · Cited by 17
Tanaka, M., Szabó, Á., & Vécsei, L. (2024) · Preprints.org · doi:10.20944/preprints202410.1193.v2 · Cited by 17
Self-citationMontaser, A. B., Lehtonen, M., Gynther, M., & Huttunen, K. M. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12040344 · Cited by 16
Kadekar, S., Nawale, G. N., Rangasami, V. K., Joncour, V. L., Laakkonen, P. M., Hilborn, J. G., Varghese, O. P., & Oommen, O. P. (2021) · Biomaterials Science · doi:10.1039/d1bm00428j · Cited by 16
Huang, J., Chen, L., Li, W., & Chang, C.-J. (2025) · Molecular Immunology · doi:10.1016/j.molimm.2025.04.008 · Cited by 16
Pallerla, S., Pires, I. S., Melo, M. B., Yun, D. S., Wagner, A., Budai, M., Kumar, D., Katinger, D., Sayeed, E., Lombardo, A. M., et al. (2025) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2025.103913 · Cited by 16
Bayesian optimization and machine learning for vaccine formulation development
Li, L., Back, S.-I., Ma, J., Guo, Y., Galeandro‐Diamant, T., & Clénet, D. (2025) · PLoS ONE · doi:10.1371/journal.pone.0324205 · Cited by 16
Maroufi, S. F., Fallahi, M. S., Maroufi, S. P., & Sheehan, J. P. (2024) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2024.110786 · Cited by 15
Araújo, C., Rodrigues, R. O., Bañobre‐López, M., Silva, A. M. T., & Ribeiro, R. S. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17040477 · Cited by 15
Плотников, М. Б., Анищенко, А. М., Khlebnikov, А. I., & Schepetkin, I. A. (2025) · Molecules · doi:10.3390/molecules30112353 · Cited by 15
Markowitz, J. C., & Milrod, B. L. (2022) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.22com14647 · Cited by 15
Cooper, J. F., Latta, K. S., & Smith, D. F. (2010) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp090290 · Cited by 14
Hußner, J., Foletti, A., Seibert, I., Fuchs, A., Schuler, E., Malagnino, V., Grube, M., & zu Schwabedissen, H. E. M. (2021) · Drug Metabolism and Pharmacokinetics · doi:10.1016/j.dmpk.2021.100418 · Cited by 14
Basavarajappa, B. S., & Subbanna, S. (2024) · Biomolecules · doi:10.3390/biom14101296 · Cited by 14
Development and Blood–Brain Barrier Penetration of Nanovesicles Loaded with Cannabidiol
Grifoni, L., Landucci, E., Pieraccini, G., Mazzantini, C., Bergonzi, M. C., Pellegrini-Giampietro, D. E., & Bilia, A. R. (2025) · Pharmaceuticals · doi:10.3390/ph18020160 · Cited by 14
Qiu, B., Pompe, S., Xenaki, K. T., Maggio, A. D., Moreno, C. B., Henegouwen, P. M. P. V. B. E., Mastrobattista, E., Oliveira, S., & Caiazzo, M. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.113852 · Cited by 14
Cited by
Dietary Polyphenols in Brain Aging: Molecular Mechanisms and Implications for Neurodegeneration
Mózes, N., Varga, J. T., Szwajgier, D., Kryczyk‐Poprawa, A., Zábó, V., Lehoczki, A., Lipécz, Á., Csípő, T., Fazekas‐Pongor, V., Major, D., et al. (2026) · Nutrients · doi:10.3390/nu18091470 · Cited by 5
“Certain low-molecular-weight polyphenols, particularly flavonoid aglycones, may cross the BBB via passive diffusion or transporter-mediated mechanisms, although evidence in humans remains limited [139].”
Li, Y., Luo, R., Li, Y., Liu, Z., Duan, X., Qin, S., He, Z., & Liu, S. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2026.119888 · Cited by 3
Zamani, N. I. S. M., Hamezah, H. S., Mediani, A., Ghazali, M., Sadikan, M. Z., & Jam, F. A. (2026) · Scientific Reports · doi:10.1038/s41598-026-53311-y · Cited by 2
“To overcome these limitations, nanoparticle-based delivery systems have been widely explored to enhance brain targeting and improve central nervous system (CNS) bioavailability of polyphenolic compounds 51 .”
Dakanalis, A., Papadopoulou, S. Κ., Mentzelou, M., Migdanis, A., Migdanis, I., & Giaginis, C. (2026) · Nutrients · doi:10.3390/nu18142362 · Cited by 3
Uti, D. E., Alum, E. U., Okpe, J. M., Egbung, J. E., & Mbah, J. O. (2026) · Tissue and Cell · doi:10.1016/j.tice.2026.103524 · Cited by 1
Metadata
- Authors
- Tanaka, M., Araujo, A. C., Valenti, V. E., Guiguer, E. L., Catharin, V. C. S., Gualhardi, C. M., de Souza Bastos Mazuqueli Pereira, E., de Alvares Goulart, R., de Argolo Haber, R. S., de Carvalho, A. C. A., & Barbalho, S. M.
- Affiliations
- University of Szeged (HU)
- Department of Biochemistry and Pharmacology, School of Medicine, Faculdade de Medicina de Marília, Universidade de Marília (UNIMAR), Marilia 17525-902, SP, Brazil
- Universidade Estadual Paulista (Unesp) (BR)
- Graduate Program in Structural and Functional Interactions in Rehabilitation, School of Medicine, Universidade de Marília (UNIMAR), Marilia 17525-902, SP, Brazil
- Corresponding author
- Tanaka, Masaru
- Barbalho, Sandra Maria
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2026-03-03
- Volume
- 27
- Issue
- 5
- Pages
- 2370
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC12985693
- OpenAlex
- W7133487442
- Cited by
- 13
- References
- 654
- Citations by year
- 2026: 13
- FWCI
- 9.92
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- Preprints.org (acceptedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- HUN-REN Hungarian Research Network (-)
- Topics
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Keywords
- blood-brain barrier, polyphenols, prodrugs, phytochemicals, nanocarriers, neurotherapeutics, intranasal drug delivery, focused ultrasound, BBB transporters, tight junctions, brain exposure, drug delivery routes, neuroinflammation, oxidative stress
- MeSH terms
- Animals, Blood-Brain Barrier, Central Nervous System Diseases, Humans, Prodrugs, Drug Delivery Systems, Nanomedicine, Polyphenols
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.